[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]

Rev Med Interne. 1993;14(10):960. doi: 10.1016/s0248-8663(05)80078-5.
[Article in French]

Abstract

Soluble CD16 (sCD16) are soluble part of Fc receptor for IgG which control in mice, proliferation of hybridoma B cells and IgG production. The levels of sCD16 in 165 myeloma patients and 29 patients with MGUS appear significantly different:25a.u./ml versus 144a.u./ml and values of stage I are significantly higher than those of stages II + III.sCD16 might be a prognosis factor in myeloma.

Publication types

  • English Abstract

MeSH terms

  • Antibodies / analysis
  • Humans
  • Multiple Myeloma / immunology*
  • Multiple Myeloma / pathology
  • Neoplasm Staging
  • Receptors, IgG / immunology*

Substances

  • Antibodies
  • Receptors, IgG